E-LIB Suche - Ergebnisse für: Wygoda, A.

1

Does Accelerated Fractionation Improve Radiation Results in..:

Wygoda, A. ; Mrochem-Kwarciak, J.J. ; Rutkowski, T....
International Journal of Radiation Oncology*Biology*Physics. 106 (2020) 5 - p. 1145 , 2020

Link: https://doi.org/10.1016/..

2

Concurrent ChemoRadiation (CCR) is better than Accelerated ..:

Księżniak-Baran, D. ; Stankiewicz, M. ; Wygoda, A....
International Journal of Radiation Oncology*Biology*Physics. 106 (2020) 5 - p. 1128 , 2020

Link: https://doi.org/10.1016/..

3

Hyperfractionated Radiotherapy Alone or in Sequential Combi..:

Wygoda, A. ; Rutkowski, T. ; Mrochem-Kwarciak, J.J....
International Journal of Radiation Oncology*Biology*Physics. 106 (2020) 5 - p. 1154 , 2020

Link: https://doi.org/10.1016/..

4

NMR-based metabolomics in real-time monitoring of treatment..:

Boguszewicz, Ł. ; Bieleń, A. ; Mrochem-Kwarciak, J....
Metabolomics. 15 (2019) 8 - p. , 2019

Link: https://doi.org/10.1007/..

5

Prognostic Value of Erythropoietin (Epo), Soluble Erythropo..:

Mrochem-Kwarciak, J.J. ; Rutkowski, T. ; Wygoda, A....
International Journal of Radiation Oncology*Biology*Physics. 105 (2019) 1 - p. E671 , 2019

Link: https://doi.org/10.1016/..

6

PO-0721 Prognostic Value of Inflammatory Markers in Patient..:

Mrochem-Kwarciak, J. ; Rutkowski, T. ; Wygoda, A...
Radiotherapy and Oncology. 133 (2019) - p. S370 , 2019

Link: https://doi.org/10.1016/..

7

Prognostic value of erythropoietin (EPO), soluble erythropo..:

Mrochem-Kwaciak, J. ; Wygoda, A. ; Deja, R....
Clinica Chimica Acta. 493 (2019) - p. S126 , 2019

Link: https://doi.org/10.1016/..

8

Prognostic Value of Reticulocyte, Immature Reticulocyte, an..:

Mrochem-Kwarciak, J.J. ; Rutkowski, T. ; Wygoda, A....
International Journal of Radiation Oncology*Biology*Physics. 100 (2018) 5 - p. 1364 , 2018

Link: https://doi.org/10.1016/..

9

SBRT of Recurrent HNC Should be Most Effective in Patients ..:

Kentnowski, M. ; Stąpór-Fudzińska, M. ; Wygoda, A....
International Journal of Radiation Oncology*Biology*Physics. 100 (2018) 5 - p. 1370-1371 , 2018

Link: https://doi.org/10.1016/..

10

Endogenic Erythropoietin Levels are Fluctuated and Conseque..:

Leś, D. ; Mrochem-Kwarciak, J.J. ; Wygoda, A...
International Journal of Radiation Oncology*Biology*Physics. 100 (2018) 5 - p. 1349 , 2018

Link: https://doi.org/10.1016/..

11

PD-027: cfHPV DNA as a marker of treatment results in patie..:

Rutkowski, T. ; Mazurek, A. ; Snietura, M....
Radiotherapy and Oncology. 122 (2017) - p. 16-17 , 2017

Link: https://doi.org/10.1016/..

12

EP-1083: HPV as an etiological and prognostic factor for th..:

Brewczyński, A. ; Rutkowski, T. ; Mazurek, A....
Radiotherapy and Oncology. 123 (2017) - p. S595-S596 , 2017

Link: https://doi.org/10.1016/..

13

PO-101: Osteopontin (OPN) as an instant, predictive marker ..:

Mrochem-Kwarciak, J. ; Rutkowski, T. ; Wygoda, A....
Radiotherapy and Oncology. 122 (2017) - p. 48-49 , 2017

Link: https://doi.org/10.1016/..

14

PO-123: Hypothyroidism after radiotherapy of head and neck ..:

Dworzecka, U. ; Wygoda, A. ; Rutkowski, T...
Radiotherapy and Oncology. 122 (2017) - p. 59 , 2017

Link: https://doi.org/10.1016/..

15

The Prognostic Value of Osteopontin (OPN) and Hemoglobin (H..:

Mrochem-Kwarciak, J.J. ; Rutkowski, T. ; Wygoda, A....
International Journal of Radiation Oncology*Biology*Physics. 99 (2017) 2 - p. E374 , 2017

Link: https://doi.org/10.1016/..